Westfield Capital Management’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,876,455	Closed	-$9.75M	–	265
2019 Q3	$9.75M	Buy	4,876,455 +51,200	+1%	+$104K	0.08%	185
2019 Q2	$10.4M	Buy	4,825,255 +37,223	+0.8%	+$95.1K	0.08%	194
2019 Q1	$15.1M	Buy	4,788,032 +50,228	+1%	+$162K	0.12%	189
2018 Q4	$11.8M	Sell	4,737,804 -36,345	-0.8%	-$121K	0.1%	184
2018 Q3	$19.2M	Buy	4,774,149 +146,195	+3%	+$645K	0.13%	184
2018 Q2	$17.5M	Buy	4,627,954 +435,920	+10%	+$1.14M	0.13%	190
2018 Q1	$9.73M	Sell	4,192,034 -486,330	-10%	-$769K	0.08%	201
2017 Q4	$7.25M	Sell	4,678,364 -180,090	-4%	-$289K	0.06%	204
2017 Q3	$10.3M	Sell	4,858,454 -427,886	-8%	-$1.46M	0.08%	203
2017 Q2	$23.9M	Buy	5,286,340 +391,392	+8%	+$1.42M	0.2%	157
2017 Q1	$14.7M	Sell	4,894,948 -183,445	-4%	-$541K	0.13%	194
2016 Q4	$14M	Sell	5,078,393 -318,614	-6%	-$911K	0.12%	201
2016 Q3	$16.9M	Buy	5,397,007 +1,487,915	+38%	+$5.42M	0.14%	184
2016 Q2	$20M	Sell	3,909,092 -59,153	-1%	-$284K	0.17%	159
2016 Q1	$16.2M	Buy	3,968,245 +126,415	+3%	+$676K	0.12%	178
2015 Q4	$31.2M	Buy	3,841,830 +619,435	+19%	+$5.16M	0.21%	140
2015 Q3	$27.2M	Buy	3,222,395 +468,885	+17%	+$4.32M	0.19%	146
2015 Q2	$25.9M	Buy	2,753,510 +516,933	+23%	+$4.82M	0.16%	167
2015 Q1	$20.7M	Buy	2,236,577 +715,390	+47%	+$6.85M	0.12%	205
2014 Q4	$14.1M	Buy	1,521,187 +790,261	+108%	+$6.65M	0.08%	223
2014 Q3	$6.53M	Buy	730,926 +453,762	+164%	+$3.3M	0.04%	231
2014 Q2	$2.18M	Sell	277,164 -22,900	-8%	-$173K	0.01%	248
2014 Q1	$2.37M	Buy	+300,064	New	+$2.41M	0.01%	254

Other funds holding CORV